Symptoms
Description:
Presently, methadone is the recommended treatment for opioid-dependent pregnant women, but is associated with neonatal abstinence syndrome (NAS). NAS is characterized by opioid withdrawal symptoms in the newborn, which often requires longer hospitalization and treatment. Buprenorphine, FDA-approved in 2002 for the treatment of opioid dependence in non-pregnant individuals, hasn't been extensively studied during pregnancy. Yet, a new study in the New England Journal of Medicine (NEJM) found that buprenorphine offers an alternative to methadone in the treatment of opioid-dependent pregnant women. The study compared buprenorphine to methadone in 131 mothers and their newborns at eight international sites.
Source:
New England Journal of Medicine
Tags:
Description:
This article provides guidance on the treatment of alcohol and drug abuse, and discusses various treatment plans.
Source:
National Institute on Drug Abuse (NIDA)
Tags:
Description:
The ASI Self-Report Form asks questions about the following topics: your background and employment, your health and family relationships, your legal situation, and your drug and alcohol use.
Source:
Center for Health Care Evaluation (CHCE)
Tags:
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
Information on why your patient should be in withdrawal before beginning buprenorphine induction.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (3 votes)
Tags:
Description:
A description of the signs of opiate withdrawal useful for physicians in determining withdrawal during medically supervised detoxification.
Source:
National Center for Biotechnology Information (2 votes)
Tags:
Description:
A checklist that allows the physician to determine if the patient is in withdrawal in order to administer initial buprenorphine dose.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
Description:
This article reviews the history of opiate withdrawal scales and their use.
Source:
The Journal of Psychoactive Drugs (2 votes)
Tags:
Description:
Provides patients with an in-depth look at what to expect from buprenorphine treatment including preparing for treatment, urine testing, counseling, and effects on sleep and relationships.
Source:
The National Alliance of Advocates for Buprenorphine Treatment (NAABT) (3 votes)
Tags:
- Patient education materials
- Addiction
- Behavioral therapy
- Confidentiality
- Induction
- Maintenance
- Side effects
- Suboxone
- Symptoms
- Urine testing
- Withdrawal
- About buprenorphine
- About opioid dependence and addiction
- How to take buprenorphine successfully
- What to expect during first treatment
- Patient education materials
- Just became waivered
- Setting up a practice
Description:
The prescribing information from the makers of Suboxone® including side effects, contraindications and drug interactions.
Source:
Reckitt Benckiser (2 votes)
Tags:
